Grant success for Dr David Chan

Dr David Chan

Dr David Chan has been successful in securing five years funding from an NHMRC Investigator Grant to continue his innovative research into understanding the behaviour of NETs such as why some NETs behave aggressively and others do not.

His main research project is focusing on dual PET scans which are currently used in Neuroendocrine neoplasms (NENs) to track disease but offer little data to guide interpretation. Dr Chan is working on developing a new method to convert dual PET into a number, describing both disease grade and the amount of tumour. 

This will make “virtual biopsies” with PET a reality – not just in NEN but other cancers such as prostate cancer as well.

We are so excited for Dr Chan and look forward to following his research over the next five years.

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NECA at ENETS 2025: Advancing NET Care on the Global Stage

The Australian Cancer Plan

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.